Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity: A single center experience and review of literature

BACKGROUND: Sinonasal mucosal melanoma (SNMM) is a rare disease entity comprising 0.4–1.3% of all melanomas. Surgery with free margins has been the primary treatment over decades. Neither the addition of radiotherapy nor chemotherapy could significantly improve outcome rates of this devastating mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrianakis, Alexandros, Kiss, Peter, Pomberger, Markus, Wolf, Axel, Thurnher, Dietmar, Tomazic, Peter Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599389/
https://www.ncbi.nlm.nih.gov/pubmed/33844113
http://dx.doi.org/10.1007/s00508-021-01847-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599389/
https://www.ncbi.nlm.nih.gov/pubmed/33844113
http://dx.doi.org/10.1007/s00508-021-01847-6

Ejemplares similares